Impact of invasive versus noninvasive blood pressure monitoring on opioid use in patients with atrial fibrillation undergoing noncardiothoracic surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400093013

Enrollment

Unknown

Registered

2024-11-27

Start date

2024-12-01

Completion date

Unknown

Last updated

2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Text group:Non-invasive blood pressure

Control group:Invasive blood pressure

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with persistent or permanent atrial fibrillation (2) Elective non-cardiothoracic surgery patients (3) American Society of Anesthesiologists (ASA) classification I ~ III (4) Body Mass Index (BMI) 17-28kg/m^2. (5) Understand the requirements of the trial and sign the informed consent form. (6) Age: 30-80 years old patients (7) Duration of surgery: not less than 1 hour.

Exclusion criteria

Exclusion criteria: (1) Excluding patients with severe cardiopulmonary diseases (2) Exclude patients with liver and kidney failure. (3) Excluding patients with allergy to anesthetics (4) Predict patients with difficult airway and congenital tracheal anatomical deformities.

Design outcomes

Secondary

Measure	Time frame
blood pressure;postoperative VAS score;	—

Primary

Measure	Time frame
Opioid dosage;	—

Countries

China

Contacts

Public ContactZhao Dizhou; Wu Chaoran

Shenzhen People’s Hospital

604020529@qq.com+86 176 2095 1866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026